載入...
Programmed death ligand‐1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder
Drugs blocking programmed death ligand‐1 (PD‐L1) have shown unprecedented activity in metastatic and unresectable bladder cancer. The purpose of the present study was to investigate the expression, clinical significance and association of PD‐L1 with tumor‐infiltrating lymphocytes (TIL) in resectable...
Na minha lista:
| 發表在: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6361576/ https://ncbi.nlm.nih.gov/pubmed/30548363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13887 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|